his talk outlines the scale of cancer in Canada and argues that traditional chemotherapy, while important, is limited by toxicity, discomfort, and poor tumor targeting. It highlights promising newer approaches including nanoparticle drug delivery, liposomal therapies, complex nanotherapies with imaging and heat generation, and future possibilities such as cancer vaccines.

This research develops peptide-based drug delivery systems to improve cancer treatment targeting. Unlike conventional therapies, peptides can selectively bind tumors, reducing systemic side effects. Using AI to design high-affinity sequences, the system enhances precision delivery and efficacy, demonstrated by reduced tumor growth in vivo compared to non-targeted treatments.

My research presents a self-administered microneedle patch made from hyaluronic acid that delivers vaccines quickly, painlessly, and effectively. Testing with a COVID-19 spike RBD antigen shows immune responses comparable to traditional injections. The patches are low-risk, easy to use, and can be stored at room temperature for a month—ideal for widespread vaccination.